Skip to main content Back to Top
Advertisement

Bipartisan Senate Proposal to Address Drug Shortages

Broadcast Date: May 29, 2024

 


Subscribe on iTune Podcasts
Listen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Members of Congress are increasingly focused on addressing drug shortages. Tom Kraus and Michael Ganio discuss a new bipartisan proposal that would use payment incentives to shift purchasing behavior to mitigate drug shortages.

Michael GanioMichael Ganio, PharmD, MS, BCSCP, FASHP joined the staff at ASHP as Director of Pharmacy Practice and Quality in January of 2018. As a member of the Center on Medication Safety and Quality team, his responsibilities span the practice of pharmacy and include drug shortages, pharmaceutical quality, sterile and non-sterile drug compounding practices, hazardous drug handling, and the ASHP Standardize 4 Safety initiative. Dr. Ganio earned his Pharm.D. from the Rutgers University Ernest Mario School of Pharmacy and his Master’s degree in Health-System Pharmacy Administration from The Ohio State University College of Pharmacy. He completed a PGY1 Pharmacy Practice residency at The Ohio State University Wexner Medical Center. Dr. Ganio is a Board Certified Pharmacotherapy Specialist (BCPS) and a Board Certified Sterile Compounding Pharmacist (BCSCP).

Tom KrausTom Kraus, JD, MHS serves as the vice president of government relations for ASHP. Kraus previously served as the deputy staff director of health on the U.S. Senate Committee on Health, Education, Labor and Pensions under Senators Edward Kennedy and Tom Harkin, where he was instrumental in the passage of key legislation, including Food and Drug Administration (FDA) drug and food safety reforms and user fee legislation, the American Recovery and Reinvestment Act, and the Affordable Care Act. Following his time on Capitol Hill, he joined the FDA, where he served as Chief of Staff and Associate FDA Commissioner for Legislation. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.  
ASHP 2020 Summer Sessions

ASHP Pharmacy Futures 2024

Welcome to our new format!
Start Here
Link the whole card
Prescriptions

Drug Shortages

Your first stop for information and resources on drug products, their availability, and management
Learn More
Link the whole card